Cytonus Therapeutics

About

Cytonus Therapeutics is a biotechnology company based in Carlsbad, California, founded in 2018. The company focuses on integrating artificial intelligence, synthetic biology, and advanced drug delivery to create next-generation precision medicines. Cytonus aims to improve drug discovery and development by addressing the high failure rates of traditional medicines, particularly for complex conditions like tumors and hard-to-reach organs. The company has developed proprietary technologies, including Cargocytes™, which are engineered for targeted drug delivery, and HIEstem™, a regenerative therapy using mesenchymal stem cells for treating conditions like Intraventricular Hemorrhage in newborns. Cytonus is also advancing a diverse drug pipeline that includes candidates for various cancers and immune disorders. Additionally, the company offers contract manufacturing services, utilizing its technologies to support healthcare and medical treatment sectors.